Healthcare & Life Sciences Industry Updates

Google News – Biopharma External News

AstraZeneca, Ionis drug fails big heart disease study in major setback - BioPharma Dive

news.google.com · 10 Jul 2026

Google News – Biopharma External News

Quantum BioPharma Provides Corporate Update - Yahoo Finance

news.google.com · 10 Jul 2026

Google News – Biopharma External News

Capital Recovery and Inclusive Research Could Define Biopharma's Next Growth Phase, Says Sara Jane Demy - BioPharm International

news.google.com · 10 Jul 2026

Google News – Biopharma External News

Recapping BIO International Convention 2026: Biopharma Eyes a Resilient Future - BioPharm International

news.google.com · 10 Jul 2026

Google News – Biopharma External News

AEON Biopharma (NASDAQ: AEON) revises S-1 filing fee table for milestone warrants - Stock Titan

news.google.com · 10 Jul 2026

Google News – Biopharma External News

Arbutus Biopharma (ABUS) Stock Looks Reasonable On Earnings But Stretched On Value - simplywall.st

news.google.com · 10 Jul 2026

Google News – Biopharma External News

Biotech executive Keating named to board of Berkeley Heights biopharma Kalaris - ROI-NJ

news.google.com · 10 Jul 2026

Google News – Biopharma External News

FDA Approves ENNUMO™ (pegfilgrastim-pccg), Accord BioPharma's Second Pegfilgrastim Biosimilar to NEULASTA® (pegfilgrastim) - PR Newswire

news.google.com · 10 Jul 2026

Google News – Biopharma External News

Vor Biopharma (VOR) director receives 42,658 stock options at $20.10 strike - Stock Titan

news.google.com · 10 Jul 2026

Google News – Biopharma External News

Agilent Strengthens Biopharma Growth Prospects With AI Expansion - Zacks Investment Research

news.google.com · 10 Jul 2026

Google News – Biopharma External News

Vor Biopharma (VOR) director submits initial Form 3 with no trades - Stock Titan

news.google.com · 10 Jul 2026

Google News – Biopharma External News

Arbutus Biopharma (ABUS) Joins Russell Defensive Indexes And Exits Value Benchmarks - Yahoo Finance

news.google.com · 10 Jul 2026

Google News – Biopharma External News

Biopharma R&D needs ‘structural redesign’ to maximize AI impact: report - BioSpace

news.google.com · 10 Jul 2026

Google News – Biopharma External News

AstraZeneca licenses Sino Biopharma respiratory drug in $200 million upfront deal - The Pharma Letter

news.google.com · 10 Jul 2026

Google_site External News

HSA Adverse Drug Reaction News 2024 December, Vol.26 No.3 - Health Professionals Portal

news.google.com · 09 Jul 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Why healthcare providers are sidelining employees amid coronavirus pandemic

For adults with prediabetes, lifestyle intervention lowered risk of developing multiple chronic conditions

New Alzheimer’s blood test may tell when symptoms are around the corner

4 takeaways from MDUFA VI draft agreement

J&J wins FDA approval for dual-energy ablation catheter

Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey

Vacancy: National Consultant (NO C) to strengthen maternal and newborn health systems.

Stanford Health Care Tri-Valley launches hospital expansion - Stanford Medicine

HHSC, UT Southwestern Medical Center celebrate opening of new psychiatric hospital in Dallas - UT Southwestern Medical

Hospital and health system leaders participate in Healthcare of Tomorrow Conference - American Hospital Association

HCA Healthcare hospitals earn 26 Press Ganey Human Experience Awards for patient experience - HCA Healthcare Today

CEO Nancy Brown named to Becker’s Hospital Review’s 2026 “Great Leaders in Healthcare” list - www.heart.org

Enhancing healthcare workers’ safety and well-being through a comprehensive qualitative analysis across hospital settings - Nature

Providers race to scale hospital-at-home before reimbursement changes - Modern Healthcare

One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2024 - KFF

How the hospital-at-home program offers alternative care as demand surges - investigatetv.com

Layoffs, closures tracker: Adventist Health cuts 132 jobs - Modern Healthcare

Experts: Cuts to federal student loans could hurt first generation students, healthcare industry - MPR News

AstraZeneca, Ionis drug fails big heart disease study in major setback - BioPharma Dive

Quantum BioPharma Provides Corporate Update - Yahoo Finance

Capital Recovery and Inclusive Research Could Define Biopharma's Next Growth Phase, Says Sara Jane Demy - BioPharm International

Recapping BIO International Convention 2026: Biopharma Eyes a Resilient Future - BioPharm International

AEON Biopharma (NASDAQ: AEON) revises S-1 filing fee table for milestone warrants - Stock Titan

Arbutus Biopharma (ABUS) Stock Looks Reasonable On Earnings But Stretched On Value - simplywall.st

Biotech executive Keating named to board of Berkeley Heights biopharma Kalaris - ROI-NJ

FDA Approves ENNUMO™ (pegfilgrastim-pccg), Accord BioPharma's Second Pegfilgrastim Biosimilar to NEULASTA® (pegfilgrastim) - PR Newswire

Vor Biopharma (VOR) director receives 42,658 stock options at $20.10 strike - Stock Titan

Agilent Strengthens Biopharma Growth Prospects With AI Expansion - Zacks Investment Research

Vor Biopharma (VOR) director submits initial Form 3 with no trades - Stock Titan

Arbutus Biopharma (ABUS) Joins Russell Defensive Indexes And Exits Value Benchmarks - Yahoo Finance

Biopharma R&D needs ‘structural redesign’ to maximize AI impact: report - BioSpace

AstraZeneca licenses Sino Biopharma respiratory drug in $200 million upfront deal - The Pharma Letter

HSA Adverse Drug Reaction News 2024 December, Vol.26 No.3 - Health Professionals Portal